美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=SOMA"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
SOMA 011792 001 NDA CARISOPRODOL TABLET;ORAL 350MG Yes No 1959/04/09 Approved Prior to Jan 1, 1982 MYLAN SPECIALITY LP Prescription
SOMA 011792 003 NDA CARISOPRODOL CAPSULE;ORAL 250MG Yes No 1959/04/09 Approved Prior to Jan 1, 1982 MYLAN SPECIALITY LP Discontinued
SOMA 011792 004 NDA CARISOPRODOL TABLET;ORAL 250MG Yes Yes 1959/04/09 2007/09/13 MYLAN SPECIALITY LP Prescription
SOMA COMPOUND 012365 005 NDA ASPIRIN; CARISOPRODOL TABLET;ORAL 325MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** No No 1960/09/12 1983/07/11 MEDA PHARMS Discontinued
SOMA COMPOUND W/ CODEINE 012366 002 NDA ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE TABLET;ORAL 325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** No No 1960/10/05 1983/07/11 MEDA PHARMS Discontinued
DOXIL (LIPOSOMAL) 050718 001 NDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 20MG/10ML (2MG/ML) Yes No 1995/11/17 1995/11/17 BAXTER HLTHCARE CORP Prescription
DOXIL (LIPOSOMAL) 050718 002 NDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 50MG/25ML (2MG/ML) Yes No 1995/11/17 2000/06/13 BAXTER HLTHCARE CORP Prescription
SOMAVERT 021106 001 BLA PEGVISOMANT INJECTABLE;SUBCUTANEOUS 10MG/VIAL No No 2003/03/25 -- PHARMACIA Prescription
SOMAVERT 021106 002 BLA PEGVISOMANT INJECTABLE;SUBCUTANEOUS 15MG/VIAL No No 2003/03/25 -- PHARMACIA Prescription
SOMAVERT 021106 003 BLA PEGVISOMANT INJECTABLE;SUBCUTANEOUS 20MG/VIAL No No 2003/03/25 -- PHARMACIA Prescription
SOMAVERT 021106 004 BLA PEGVISOMANT INJECTABLE;SUBCUTANEOUS 25MG/VIAL No No 2003/03/25 -- PHARMACIA Prescription
SOMAVERT 021106 005 BLA PEGVISOMANT INJECTABLE;SUBCUTANEOUS 30MG/VIAL No No 2003/03/25 -- PHARMACIA Prescription
SOMATULINE DEPOT 022074 001 NDA LANREOTIDE ACETATE SOLUTION;SUBCUTANEOUS EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) Yes Yes 2007/08/30 2007/08/30 IPSEN PHARMA Prescription
SOMATULINE DEPOT 022074 002 NDA LANREOTIDE ACETATE SOLUTION;SUBCUTANEOUS EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) Yes Yes 2007/08/30 2007/08/30 IPSEN PHARMA Prescription
SOMATULINE DEPOT 022074 003 NDA LANREOTIDE ACETATE SOLUTION;SUBCUTANEOUS EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) Yes Yes 2007/08/30 2007/08/30 IPSEN PHARMA Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 203263 001 ANDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 20MG/10ML (2MG/ML) No Yes 2013/02/04 2013/02/04 SUN PHARM Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 203263 002 ANDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 50MG/25ML (2MG/ML) No Yes 2013/02/04 2013/02/04 SUN PHARM Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 208657 001 ANDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 20MG/10ML (2MG/ML) No No 2017/05/15 2017/05/15 DR REDDYS Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 208657 002 ANDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 50MG/25ML (2MG/ML) No No 2017/05/15 2017/05/15 DR REDDYS Prescription
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) 212299 001 ANDA DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL;INJECTION 20MG/10ML (2MG/ML) No No 2020/09/10 2020/09/10 ZYDUS LIFESCIENCES Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database